ATE193451T1 - Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen - Google Patents

Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen

Info

Publication number
ATE193451T1
ATE193451T1 AT95908853T AT95908853T ATE193451T1 AT E193451 T1 ATE193451 T1 AT E193451T1 AT 95908853 T AT95908853 T AT 95908853T AT 95908853 T AT95908853 T AT 95908853T AT E193451 T1 ATE193451 T1 AT E193451T1
Authority
AT
Austria
Prior art keywords
verotoxin
pharmaceutical compositions
medical treatments
neoplastic
verotoxins
Prior art date
Application number
AT95908853T
Other languages
English (en)
Inventor
Clifford A Lingwood
Richard Hill
Hannah Farkas-Himsley
Original Assignee
Geva Ruth Executor For The Dec
Kroyanker Leorah Executor For
Clifford A Lingwood
Richard Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geva Ruth Executor For The Dec, Kroyanker Leorah Executor For, Clifford A Lingwood, Richard Hill filed Critical Geva Ruth Executor For The Dec
Application granted granted Critical
Publication of ATE193451T1 publication Critical patent/ATE193451T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
AT95908853T 1994-02-22 1995-02-20 Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen ATE193451T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002116179A CA2116179C (en) 1994-02-22 1994-02-22 Verotoxin pharmaceutical compositions and medical treatments therewith
PCT/CA1995/000085 WO1995022349A1 (en) 1994-02-22 1995-02-20 Verotoxin pharmaceutical compositions and medical treatments therewith

Publications (1)

Publication Number Publication Date
ATE193451T1 true ATE193451T1 (de) 2000-06-15

Family

ID=4152948

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95908853T ATE193451T1 (de) 1994-02-22 1995-02-20 Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen

Country Status (10)

Country Link
US (1) US6228370B1 (de)
EP (1) EP0746337B1 (de)
JP (1) JPH10500103A (de)
AT (1) ATE193451T1 (de)
AU (1) AU701100B2 (de)
CA (1) CA2116179C (de)
DE (1) DE69517302T2 (de)
ES (1) ES2149347T3 (de)
NZ (1) NZ331165A (de)
WO (1) WO1995022349A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835710B1 (en) * 1994-02-22 2004-12-28 Hsc Research & Development Limited Partnership Verotoxin pharmaceutical compositions and medical treatments therewith
WO1998051326A1 (en) * 1997-05-16 1998-11-19 Hsc Research And Development Limited Partnership Inhibition of angiogenesis by verotoxins
DE69932719T2 (de) 1998-05-20 2007-09-13 Teijin Ltd. Humanisierte Antikörper zur Erkennung von Verotoxin II sowie Zelllinie zur Herstellung derselben
WO2000061183A2 (en) * 1999-04-09 2000-10-19 Hsc Research And Development Limited Partnership Verotoxin treatment of lymphomas
WO2000066714A2 (en) * 1999-05-03 2000-11-09 The Governors Of The University Of Alberta Shiga-like toxin as an enriching and purging agent
US20050163807A1 (en) 2002-02-04 2005-07-28 Xiaoyan Liu Anticancer agents using vero toxin variants

Also Published As

Publication number Publication date
WO1995022349A1 (en) 1995-08-24
JPH10500103A (ja) 1998-01-06
US6228370B1 (en) 2001-05-08
AU1703195A (en) 1995-09-04
CA2116179C (en) 2008-01-08
EP0746337B1 (de) 2000-05-31
DE69517302D1 (de) 2000-07-06
EP0746337A1 (de) 1996-12-11
AU701100B2 (en) 1999-01-21
CA2116179A1 (en) 1995-08-23
NZ331165A (en) 2000-01-28
ES2149347T3 (es) 2000-11-01
DE69517302T2 (de) 2001-01-18

Similar Documents

Publication Publication Date Title
CY1121447T1 (el) Συνθεσεις για αυξηση δραστηριοτητας τελομερασης
FI884013A0 (fi) Konjugat av cytokiner med immunoglobuliner.
PT933995E (pt) Metodo para tratamento de lesao endotelial
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
IL182352A (en) Use of et-743 in the preparation of a medicament for treating cancer and medical kits containing et-743
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
GEP20043202B (en) Resorcinol Derivatives
DE69517302D1 (de) Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen
DE69734574D1 (de) Rekombinante adenovirenvektoren zur gentherapie der menschlichen krebse
AR016254A1 (es) Una composicion de celulas de tumor modificadas con un hapteno o extracto de celulas tumorales y uso de la misma en la elaboracion de un medicamento.
TR200401810T4 (tr) Kısırlık tedavisinde fsh'ın kullanılması
ATE428438T1 (de) Tcf-ii enthaltende medizinische zusammensetzung
ATE128964T1 (de) Anwendung von beta-alethin in zellkultur und therapie.
ATE141510T1 (de) Arzneimittel enthaltend cd14
CA2163716A1 (en) Verotoxin pharmaceutical compositions and medical treatments therewith
ATE83657T1 (de) Pharmazeutische zusammensetzung.
PT1150981E (pt) Composto nucleosidico terapeutico
RU94021815A (ru) Способ лечения злокачественных новообразований
DK0455769T3 (da) Anvendelse af 7-OH-1,2-benzopyron til fremstilling af et lægemiddel til behandling af magline tumore r hos mennesker

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee